Hepatic JNK-mediated bile acid homeostasis regulates liver cancer through PPARα
Manieri, E.; Esteban-Lafuente, L.; Rodriguez, E.; Leiva-Vega, L.; Chen, C.; Cubero, F. J.; Barrett, T.; Cavanagh-Kyros, J.; Seruggia, D.; Monte, M. J.; Marin, J. J.; Davis, R. R. J.; Mora, A.; Sabio, G.
Show abstract
cJun NH2-terminal kinase (JNK) inhibition has been suggested as a potential treatment for insulin resistance and steatosis through activation of the transcription factor PPAR. However, the long-term consequences have not been evaluated. We found that hepatic JNK deficiency alters bile acid and cholesterol metabolism, resulting in hepatic expression of FGF15 and activation of ERK in cholangiocytes, which ultimately promotes their proliferation. Genetic inactivation of PPAR identifies PPAR hyperactivation as the molecular mechanism for these deleterious effects. Our analysis indicates that hepatic PPAR activation is oncogenic: PPAR deficiency protects mice against carcinogen-induced hepatocellular carcinoma under high fat diet (HFD) condition. These surprising results urge the re-consideration of using JNK inhibitors or PPAR agonists for the treatment of metabolic syndrome.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A Host Enzyme Reduces Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by Inactivating Intestinal Lipopolysaccharide 97%
- Melanocortin 1 receptor regulates cholesterol and bile acid metabolism in the liver 97%
- β-Catenin-NFκB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction 96%
Similar papers in this journal
- CD73 maintains hepatocyte metabolic integrity and mouse liver homeostasis in a sex-dependentmanner 97%
- Overlapping yet Distinct Functions of VMP1 and TMEM41B in Modulating Hepatic Lipoprotein Secretion and Autophagy 95%
- Gut dysbiosis protects against liver injury in autophagy deficient mice by FXR-FGF15 feedback signaling 95%
Similar papers in this journal
- RIP3 and MLKL regulate Hepatic ER stress in alcohol-associated liver disease and pharmacological ER stress models: insights beyond necroptosis 95%
- p53 and TIGAR promote redox control to protect against metabolic dysfunction-associated steatohepatitis 95%
- Constitutive Androstane Receptor contributes towards increased drug clearance in cholestasis 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.